Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh Rosen

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Prostaglandins & Other Lipid Mediators|August 16, 2005
Chemical approaches to the lysophospholipid receptorsHugh Rosen
Gastroenterology & Hepatology|May 26, 2021
The Role of Small Molecule Inhibition of Leukocyte Trafficking in Inflammatory Bowel DiseaseHugh Rosen
Current Pharmaceutical Design|February 4, 2006
Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseasesJerold Chun, Hugh Rosen
Current Opinion in Chemical Biology|August 28, 2003
Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigmHugh Rosen, Jiayu Liao
Advances in Pharmacology (San Diego, Calif.)|November 9, 2024
The discovery and development of the sphingosine 1-phosphate receptor modulator ozanimod in ulcerative colitisHugh Rosen, Edward Roberts
Nature Reviews. Drug Discovery|March 21, 2009
Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic moleculesDavid Marsolais, Hugh Rosen
Nature Chemical Biology|May 19, 2009
S1P1 signaling just keeps going and going and goingStuart Cahalan, Hugh Rosen
Nature Reviews. Immunology|July 7, 2005
Sphingosine 1-phosphate and its receptors: an autocrine and paracrine networkHugh Rosen, Edward J Goetzl
Analytical Biochemistry|January 22, 2008
A fluorescent plate reader assay for ceramide kinaseAnthony S Don, Hugh Rosen
Biochemical and Biophysical Research Communications|January 27, 2009
A lipid binding domain in sphingosine kinase 2Anthony S Don, Hugh Rosen
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Prostaglandins & Other Lipid Mediators|August 16, 2005
Chemical approaches to the lysophospholipid receptorsHugh Rosen
Gastroenterology & Hepatology|May 26, 2021
The Role of Small Molecule Inhibition of Leukocyte Trafficking in Inflammatory Bowel DiseaseHugh Rosen
Current Pharmaceutical Design|February 4, 2006
Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseasesJerold Chun, Hugh Rosen
Current Opinion in Chemical Biology|August 28, 2003
Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigmHugh Rosen, Jiayu Liao
Advances in Pharmacology (San Diego, Calif.)|November 9, 2024
The discovery and development of the sphingosine 1-phosphate receptor modulator ozanimod in ulcerative colitisHugh Rosen, Edward Roberts
Nature Reviews. Drug Discovery|March 21, 2009
Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic moleculesDavid Marsolais, Hugh Rosen
Nature Chemical Biology|May 19, 2009
S1P1 signaling just keeps going and going and goingStuart Cahalan, Hugh Rosen
Nature Reviews. Immunology|July 7, 2005
Sphingosine 1-phosphate and its receptors: an autocrine and paracrine networkHugh Rosen, Edward J Goetzl
Analytical Biochemistry|January 22, 2008
A fluorescent plate reader assay for ceramide kinaseAnthony S Don, Hugh Rosen
Biochemical and Biophysical Research Communications|January 27, 2009
A lipid binding domain in sphingosine kinase 2Anthony S Don, Hugh Rosen
Pageof 13